Literature DB >> 4278421

Long-term administration of desferrioxamine in thalassaemia major.

R Seshadri, J H Colebatch, P Gordon, H Ekert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4278421      PMCID： PMC1648977          DOI： 10.1136/adc.49.8.621

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  17 in total

1.  EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD.

Authors:  Y F HWANG; E B BROWN
Journal:  Arch Intern Med       Date:  1964-12

2.  Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis.

Authors:  J T ELLIS; I SCHULMAN; C H SMITH
Journal:  Am J Pathol       Date:  1954 Mar-Apr       Impact factor: 4.307

3.  Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy.

Authors:  C Wasi; P Wasi; P Thongcharoen
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

4.  Clinical experience with intensive transfusion therapy in Cooley's anemia.

Authors:  M E Beard; T F Necheles; D M Allen
Journal:  Ann N Y Acad Sci       Date:  1969-11-20       Impact factor: 5.691

5.  Urinary iron excretion in thalassaemia after desferrioxamine administration.

Authors:  R Seshadri; J H Colebatch; R Fisher
Journal:  Arch Dis Child       Date:  1974-03       Impact factor: 3.791

6.  EXcretion and distribution of iron during chronic deferoxamine therapy.

Authors:  J N Lukens; L A Neuman
Journal:  Blood       Date:  1971-11       Impact factor: 22.113

Review 7.  Clinical usefulness of iron chelating agents.

Authors:  H S Waxman; E B Brown
Journal:  Prog Hematol       Date:  1969

8.  Desferrioxamine in thalassaemia.

Authors:  M Diwany; M Gabr; A el Hefni; N Mokhtar
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

9.  Iron excretion in thalassemia after the administration of chelating agents.

Authors:  A H Markum; W Iskandar; K L Keng; O Odang
Journal:  Paediatr Indones       Date:  1969 May-Jun

10.  Deferoxamine and diethylenetriaminepentaacetic acid (DTPA) in thalassemia.

Authors:  R McDonald
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406
View more
  5 in total

1.  Total management of thalassaemia major.

Authors:  B Modell
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

Review 2.  Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Gerardo Nigro
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-06-20       Impact factor: 1.468

3.  Electrocardiographic consequences of cardiac iron overload in thalassemia major.

Authors:  Jon Detterich; Leila Noetzli; Fred Dorey; Yaniv Bar-Cohen; Paul Harmatz; Thomas Coates; John Wood
Journal:  Am J Hematol       Date:  2011-11-04       Impact factor: 10.047

4.  Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.

Authors:  G E Janka; P Möhring; M Helmig; R J Haas; K Betke
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

5.  Korean guideline for iron chelation therapy in transfusion-induced iron overload.

Authors:  Jun Ho Jang; Je-Hwan Lee; Sung-Soo Yoon; Deog-Yeon Jo; Hyeoung-Joon Kim; Jooseop Chung; Jong Wook Lee
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.